Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'neuropeptide y 13 36 porcine'

Search results for: 'neuropeptide y 13 36 porcine'

Items 1-10 of 41

Page
per page
  1. Y-27632 dihydrochloride
    A3008 Y-27632 dihydrochloride
     19 Citation
    Target: ROCK
    Summary: ROCK1 inhibitor
      ≥111.2 mg/mL
  2. Peptide YY(3-36), PYY, human
    A1115 Peptide YY(3-36), PYY, human
    Target: NPY Receptors
    Summary: Y2R agonist
      ≥405 mg/mL
  3. NNC 55-0396
    A3662 NNC 55-0396
    Target: Voltage-gated Calcium Channels (CaV)
    Summary: T-type calcium channel blocker
      Soluble to 25 mM in sterile water
  4. BMS-378806
    B1533 BMS-378806
     1 Citation
    Target: gp120/CD4
    Summary: Gp120/CD4 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥20.2 mg/mL
  5. Ki16198
    B1591 Ki16198
    Target: LPA Receptors
    Summary: LPA antagonist
  6. MK-2206 dihydrochloride
    A3010 MK-2206 dihydrochloride
     21 Citation
    Target: Akt
    Summary: Akt1/2/3 inhibitor
      insoluble in EtOH; ≥12.01 mg/mL
  7. MLN8054
    A4114 MLN8054
    Target: Aurora Kinases
    Summary: Aurora A inhibitor
      insoluble in EtOH; insoluble in H2O; ≥39.05 mg/mL
  8. Tolcapone
    A4383 Tolcapone
    Target: Catechol O-Methyltransferase (COMT)
    Summary: COMT inhibitor
      insoluble in H2O; ≥12 mg/mL
  9. Lithium carbonate
    B7705 Lithium carbonate
    Target: Na /K ATPases
    Summary: Na+/K+ ATPase pump inhibitor
      insoluble in EtOH; ≥2.74 mg/mL
  10. LY 294002
    A8250 LY 294002
     16 Citation
    Target: PI3K
    Summary: Potent PI3K inhibitor

Items 1-10 of 41

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Lab Reagents 1 item
Reversibility
  1. Reversible 3item
Target
  1. Histone Deacetylases (HDACs) 2item
  2. Akt 1 item
  3. PI3K 4item
  4. CXCR 1 item
  5. Raf 2item
  6. Aurora Kinases 2item
  7. mTOR 2item
  8. MMP 3item
  9. Androgen Receptors 1 item
  10. FLT3 2item
  11. LPA Receptors 1 item
  12. P-glycoprotein (P-gp) 1 item
  13. Eph Receptors 1 item
  14. VEGFR 4item
  15. PDGFR 4item
  16. c-Kit 2item
  17. RET 1 item
  18. Phosphodiesterases (PDEs) 1 item
  19. Bcr-Abl 2item
  20. FGFR 2item
  21. Src 1 item
  22. ROCK 1 item
  23. PAK 1 item
  24. p300 1 item
  25. DNA-PK 3item
  26. HSP90 1 item
  27. RAD51 1 item
  28. LRRK2 1 item
  29. Voltage-gated Calcium Channels (CaV) 1 item
  30. Melanocortin (MC) Receptors 1 item
  31. HIV-1 gp120 1 item
  32. Glutamate (Metabotropic) Group I Receptors 1 item
  33. NPY Receptors 1 item
  34. Na /K ATPases 1 item
  35. P110 1 item
  36. Hck 1 item
  37. Catechol O-Methyltransferase (COMT) 1 item
  38. angiogenesis 1 item
  39. DCLK2 1 item
  40. gp120/CD4 1 item
  41. ATM 1 item
Related Disease
  1. Adrenocortical Carcinoma 1 item
  2. Bladder Cancer 1 item
  3. Brain Injuries Studies 1 item
  4. Breast Cancer 4item
  5. Cancer 26item
  6. Chronic Lymphocytic Leukemia 2item
  7. Chronic Myeloproliferative Disorders 1 item
  8. Clear Cell Renal Cell Carcinoma 1 item
  9. Cocaine-Related Disorders 1 item
  10. Colon Cancer 2item
  11. Colorectal Cancer 3item
  12. Glioblastoma 2item
  13. Glioma 3item
  14. HIV 2item
  15. Leukemia 3item
  16. Lung Cancer 2item
  17. Lymphoma 1 item
  18. Melanoma 1 item
  19. Multiple Myeloma 3item
  20. Myelofibrosis 1 item
  21. Neuroblastoma 3item
  22. Neurocognitive Disorders 1 item
  23. Non-small Cell Lung Carcinoma 1 item
  24. Obsessive-Compulsive Disorder 1 item
  25. Osteoporosis 1 item
  26. Ovarian Cancer 2item
  27. Pancreatic Cancer 3item
  28. Prostate Cancer 3item
  29. Pulmonary Fibrosis 1 item
  30. Renal Cancer 1 item
  31. Schizophrenia 1 item
  32. Soft Tissue Sarcoma 1 item
  33. Thyroid Cancer 1 item